Binding of the wheat germ lectin to Cryptococcus neoformans chitooligomers affects multiple mechanisms required for fungal pathogenesis

Fungal Genetics and Biology

Volumn 60, Issue , 2013, Pages 64-73

  Fonseca, Fernanda L ^a   Guimarães, Allan J ^b   Kmetzsch, Lívia ^c   Dutra, Fabianno F ^a   Silva, Fernanda D ^d,h   Taborda, Carlos P ^d   Araujo, Glauber de S ^a,e   Frases, Susana ^a,e   Staats, Charley C ^c   Bozza, Marcelo T ^a   Schrank, Augusto ^c   Vainstein, Marilene H ^c   Nimrichter, Leonardo ^a   Casadevall, Arturo ^f   Rodrigues, Marcio L ^a,g  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

^e INSTITUTO NACIONAL DE METROLOGIA   (Brazil)

^f ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^g INSTITUTO OSWALDO CRUZ   (Brazil)

^h UNIVERSIDADE FEDERAL DO ABC   (Brazil)

Author keywords

Capsule; Chitin oligosaccharides; Cryptococcus neoformans; Lectin binding; Virulence

Indexed keywords

CHITOOLIGOMER; GLUCURONOXYLOMANNAN; OLIGOMER; UNCLASSIFIED DRUG; WHEAT GERM AGGLUTININ;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARBOHYDRATE TRANSPORT; CELL INTERACTION; CELL STRUCTURE; CELL SURFACE; CONTROLLED STUDY; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; FEMALE; FUNGAL CAPSULE; FUNGAL COLONIZATION; FUNGAL VIABILITY; FUNGUS GROWTH; HOST CELL; INHIBITION KINETICS; MALE; MORTALITY; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BINDING;

ANIMALIA; FILOBASIDIELLA NEOFORMANS; MUS; TRITICUM AESTIVUM;

CAPSULE; CHITIN OLIGOSACCHARIDES; CRYPTOCOCCUS NEOFORMANS; LECTIN BINDING; VIRULENCE;

ANIMALS; BRAIN; CHITIN; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; FUNGAL CAPSULES; MACROPHAGES; MICE; MICE, INBRED C57BL; PHAGOCYTOSIS; POLYSACCHARIDES; WHEAT GERM AGGLUTININS;

EID: 84887615780     PISSN: 10871845     EISSN: 10960937     Source Type: Journal    
DOI: 10.1016/j.fgb.2013.04.005     Document Type: Article

References (62)

1. Albuquerque P.C., Rodrigues M.L. Research trends on pathogenic Cryptococcus species in the last 20 years: a global analysis with focus on Brazil. Future Microbiol. 2012, 7:319-329.
2. Alspaugh J.A., et al. Cryptococcus neoformans mating and virulence are regulated by the G-protein alpha subunit GPA1 and cAMP. Genes Dev. 1997, 11:3206-3217.
3. Barbosa F.M., et al. Glucuronoxylomannan-mediated interaction of Cryptococcus neoformans with human alveolar cells results in fungal internalization and host cell damage. Microb. Infect. 2006, 8:493-502.
4. Bittencourt V.C., et al. An alpha-glucan of Pseudallescheria boydii is involved in fungal phagocytosis and Toll-like receptor activation. J. Biol. Chem. 2006, 281:22614-22623.
5. Casadevall A. Cryptococci at the brain gate: break and enter or use a Trojan horse?. J. Clin. Invest. 2010, 120:1389-1392.
6. Casadevall A., et al. Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies. Antimicrob. Agents Chemother. 1998, 42:1437-1446.
7. Casadevall A., et al. Monoclonal antibody based ELISAs for cryptococcal polysaccharide. J. Immunol. Methods 1992, 154:27-35.
8. Casadevall A., et al. Vesicular transport across the fungal cell wall. Trends Microbiol. 2009, 17:158-162.
9. Chang Y.C., et al. Structure and biological activities of acapsular Cryptococcus neoformans 602 complemented with the CAP64 gene. Infect. Immun. 1997, 65:1584-1592.
10. Chang Y.C., Kwon-Chung K.J. Isolation of the third capsule-associated gene, CAP60, required for virulence in Cryptococcus neoformans. Infect. Immun. 1998, 66:2230-2236.
11. Chang Y.C., Kwon-Chung K.J. Isolation, characterization, and localization of a capsule-associated gene, CAP10, of Cryptococcus neoformans. J. Bacteriol. 1999, 181:5636-5643.
12. Chang Y.C., et al. The second capsule gene of Cryptococcus neoformans, CAP64, is essential for virulence. Infect. Immun. 1996, 64:1977-1983.
13. Chang Y.C., et al. Further analysis of the CAP59 locus of Cryptococcus neoformans: structure defined by forced expression and description of a new ribosomal protein-encoding gene. Gene 1995, 167:179-183.
14. Charlier C., et al. Evidence of a role for monocytes in dissemination and brain invasion by Cryptococcus neoformans. Infect. Immun. 2009, 77:120-127.
15. Chen C., Contreras R. The bud scar-based screening system for hunting human genes extending life span. Ann. NY Acad. Sci. 2004, 1019:355-359.
16. Ciopraga J., et al. Fusarium sp. growth inhibition by wheat germ agglutinin. Biochim. Biophys. Acta. 1999, 1428:424-432.
17. Cordero R.J., et al. Antibody binding to Cryptococcus neoformans impairs budding by altering capsular mechanical properties. J. Immunol. 2013, 190:317-323.
18. D'Souza C.A., et al. Cyclic AMP-dependent protein kinase controls virulence of the fungal pathogen Cryptococcus neoformans. Mol. Cell Biol. 2001, 21:3179-3191.
19. Da Silva C.A., et al. Chitin is a size-dependent regulator of macrophage TNF and IL-10 production. J. Immunol. 2009, 182:3573-3582.
20. Da Silva C.A., et al. TLR-2 and IL-17A in chitin-induced macrophage activation and acute inflammation. J. Immunol. 2008, 181:4279-4286.
21. Del Poeta M. Role of phagocytosis in the virulence of Cryptococcus neoformans. Eukaryot. Cell. 2004, 3:1067-1075.
22. Doering T.L. How sweet it is! Cell wall biogenesis and polysaccharide capsule formation in Cryptococcus neoformans. Annu. Rev. Microbiol. 2009, 63:223-247.
23. Feldmesser M., et al. Intracellular parasitism of macrophages by Cryptococcus neoformans. Trends Microbiol. 2001, 9:273-278.
24. Figueiredo R.T., et al. Fungal surface and innate immune recognition of filamentous fungi. Front Microbiol. 2011, 2:248.
25. Figueiredo R.T., et al. TLR4 recognizes Pseudallescheria boydii conidia and purified rhamnomannans. J. Biol. Chem. 2010, 285:40714-40723.
26. Fonseca F.L., et al. Role for chitin and chitooligomers in the capsular architecture of Cryptococcus neoformans. Eukaryot. Cell. 2009, 8:1543-1553.
27. Garcia-Rivera J., et al. Cryptococcus neoformans CAP59 (or Cap59p) is involved in the extracellular trafficking of capsular glucuronoxylomannan. Eukaryot. Cell. 2004, 3:385-392.
28. Gillece J.D., et al. Whole genome sequence analysis of Cryptococcus gattii from the Pacific Northwest reveals unexpected diversity. PLoS One 2011, 6:e28550.
29. Goldman D., et al. Pathogenesis of pulmonary Cryptococcus neoformans infection in the rat. Infect Immun. 1994, 62:4755-4761.
30. Kechichian T.B., et al. Depletion of alveolar macrophages decreases the dissemination of a glucosylceramide-deficient mutant of Cryptococcus neoformans in immunodeficient mice. Infect Immun. 2007, 75:4792-4798.
31. Klutts J.S., et al. Glycosyltransferases and their products: cryptococcal variations on fungal themes. FEMS Yeast Res. 2006, 6:499-512.
32. Kmetzsch L., et al. Role for Golgi reassembly and stacking protein (GRASP) in polysaccharide secretion and fungal virulence. Mol. Microbiol. 2011, 81:206-218.
33. Kmetzsch L., et al. Calcium signaling components in the human pathogen: Cryptococcus neoformans. Commun. Integr. Biol. 2011, 4:186-187.
34. Kmetzsch L., et al. The vacuolar Ca(2)(+) exchanger Vcx1 is involved in calcineurin-dependent Ca(2)(+) tolerance and virulence in Cryptococcus neoformans. Eukaryot. Cell. 2010, 9:1798-1805.
35. Kmetzsch L., et al. The GATA-type transcriptional activator Gat1 regulates nitrogen uptake and metabolism in the human pathogen Cryptococcus neoformans. Fungal Genet. Biol. 2011, 48:192-199.
36. Levitz S.M. Receptor-mediated recognition of Cryptococcus neoformans. Nihon Ishinkin Gakkai Zasshi 2002, 43:133-136.
37. Levitz S.M. Interactions of Toll-like receptors with fungi. Microb. Infect. 2004, 6:1351-1355.
38. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
39. Loftus B.J., et al. The genome of the basidiomycetous yeast and human pathogen Cryptococcus neoformans. Science 2005, 307:1321-1324.
40. Marim F.M., et al. A method for generation of bone marrow-derived macrophages from cryopreserved mouse bone marrow cells. PLoS One 2010, 5:e15263.
41. McClelland E.E., et al. Ab binding alters gene expression in Cryptococcus neoformans and directly modulates fungal metabolism. J. Clin. Invest. 2010, 120:1355-1361.
42. Mirelman D., et al. Inhibition of fungal growth by wheat germ agglutinin. Nature 1975, 256:414-416.
43. Nakamura K., et al. Limited contribution of Toll-like receptor 2 and 4 to the host response to a fungal infectious pathogen, Cryptococcus neoformans. FEMS Immunol. Med. Microbiol. 2006, 47:148-154.
44. O'Brien X.M., et al. Lectin site ligation of CR3 induces conformational changes and signaling. J. Biol. Chem. 2012, 287:3337-3348.
45. Orgad U., et al. Histochemical studies of epithelial cell glycoconjugates in atrophic, metaplastic, hyperplastic, and neoplastic canine prostate. Lab Invest. 1984, 50:294-302.
46. Park B.J., et al. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 2009, 23:525-530.
47. Ramos C.L., et al. Chitin-like molecules associate with Cryptococcus neoformans glucuronoxylomannan to form a glycan complex with previously unknown properties. Eukaryot. Cell. 2012, 11:1086-1094.
48. Rodrigues M.L., et al. Binding of the wheat germ lectin to Cryptococcus neoformans suggests an association of chitinlike structures with yeast budding and capsular glucuronoxylomannan. Eukaryot. Cell. 2008, 7:602-609.
49. Rodrigues M.L., Nimrichter L. In good company: association between fungal glycans generates molecular complexes with unique functions. Front Microbiol. 2012, 3:249.
50. Rodrigues M.L., et al. Vesicular polysaccharide export in Cryptococcus neoformans is a eukaryotic solution to the problem of fungal trans-cell wall transport. Eukaryot. Cell. 2007, 6:48-59.
51. Rodrigues M.L., et al. Monoclonal antibody to fungal glucosylceramide protects mice against lethal Cryptococcus neoformans infection. Clin. Vaccine Immunol. 2007, 14:1372-1376.
52. Roy M., Chiller T. Preventing deaths from cryptococcal meningitis: from bench to bedside. Exp. Rev. Anti Infect. Ther. 2011, 9:715-717.
53. Sommer U., et al. An alpha-1,3-mannosyltransferase of Cryptococcus neoformans. J. Biol. Chem. 2003, 278:47724-47730.
54. Wills E.A., et al. Identification and characterization of the Cryptococcus neoformans phosphomannose isomerase-encoding gene, MAN1, and its impact on pathogenicity. Mol. Microbiol. 2001, 40:610-620.
55. Wozniak K.L., et al. Role of IL-17A on resolution of pulmonary C. neoformans infection. PLoS One 2011, 6:e17204.
56. Yauch L.E., et al. Receptor-mediated clearance of Cryptococcus neoformans capsular polysaccharide in vivo. Infect Immun. 2005, 73:8429-8432.
57. Yauch L.E., et al. Involvement of CD14, toll-like receptors 2 and 4, and MyD88 in the host response to the fungal pathogen Cryptococcus neoformans in vivo. Infect Immun. 2004, 72:5373-5382.
58. Yoneda A., Doering T.L. A eukaryotic capsular polysaccharide is synthesized intracellularly and secreted via exocytosis. Mol. Biol. Cell. 2006, 17:5131-5140.
59. Zaragoza O., Casadevall A. Experimental modulation of capsule size in Cryptococcus neoformans. Biol. Proced. Online 2004, 6:10-15.
60. Zaragoza O., et al. The capsule of the fungal pathogen Cryptococcus neoformans. Adv. Appl. Microbiol. 2009, 68:133-216.
61. Zaragoza O., et al. The polysaccharide capsule of the pathogenic fungus Cryptococcus neoformans enlarges by distal growth and is rearranged during budding. Mol. Microbiol. 2006, 59:67-83.
62. Zou C., et al. Murine hyperglycemic vasculopathy and cardiomyopathy: whole-genome gene expression analysis predicts cellular targets and regulatory networks influenced by mannose binding lectin. Front Immunol. 2012, 3.